These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38771337)
1. Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma - a prospective study over two years. Gassel CJ; Wenzel DA; Nasyrov E; Strasser T; Voykov B Graefes Arch Clin Exp Ophthalmol; 2024 May; ():. PubMed ID: 38771337 [TBL] [Abstract][Full Text] [Related]
2. PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study. Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Kohlhaas M Cureus; 2022 Aug; 14(8):e28288. PubMed ID: 36158358 [TBL] [Abstract][Full Text] [Related]
3. Efficacy, Confounders and Safety of the Preserflo Microshunt. Altas C; Fuchsluger TA; Brockmann T; Graumüller A; Walckling M Klin Monbl Augenheilkd; 2024 Sep; 241(9):1048-1056. PubMed ID: 39047762 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort. Storp JJ; Vietmeier FE; Merté RL; Koch R; Zimmermann JA; Eter N; Brücher VC J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445509 [TBL] [Abstract][Full Text] [Related]
5. Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation. Vastardis I; Fili S; Perdikakis G; Kontopoulou K; Balidis M; Gatzioufas Z; Kohlhaas M Eye Vis (Lond); 2021 Sep; 8(1):33. PubMed ID: 34479641 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study. Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904 [TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of the Preserflo Majoulet A; Scemla B; Hamard P; Brasnu E; Hage A; Baudouin C; Labbé A J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498660 [No Abstract] [Full Text] [Related]
8. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom. Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750 [TBL] [Abstract][Full Text] [Related]
9. Histopathological findings of failed blebs after microinvasive bleb surgery with the XEN Gel Stent and Preserflo MicroShunt. Neubauer J; Suesskind D; Gassel CJ; Nasyrov E; Voykov B Graefes Arch Clin Exp Ophthalmol; 2024 Sep; 262(9):2977-2984. PubMed ID: 38625448 [TBL] [Abstract][Full Text] [Related]
10. One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma. Seuthe AM; Erokhina M; Szurman P; Haus A J Glaucoma; 2023 May; 32(5):414-419. PubMed ID: 36795529 [TBL] [Abstract][Full Text] [Related]
11. PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma. Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Bechrakis N; Kohlhaas M J Curr Ophthalmol; 2022; 34(2):180-186. PubMed ID: 36147269 [TBL] [Abstract][Full Text] [Related]
12. Device-modified trabeculectomy for glaucoma. Park J; Rittiphairoj T; Wang X; E JY; Bicket AK Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010472. PubMed ID: 36912740 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of PreserFlo MicroShunt Implantation and Its Effects on Intraocular Inflammation through Laser Flare Photometry. Cagini C; Boni N; Bonifazi T; Fruttini D; Della Lena F J Ophthalmol; 2024; 2024():2447721. PubMed ID: 39081855 [TBL] [Abstract][Full Text] [Related]
15. Changes to Corneal Topography and Biometrics After PRESERFLO Microshunt Surgery for Glaucoma. Ibarz Barberá M; Morales-Fernandez L; Gómez de Liaño R; Tañá Rivero P; Teus MA J Glaucoma; 2021 Oct; 30(10):921-931. PubMed ID: 34255755 [TBL] [Abstract][Full Text] [Related]
16. One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis. Tanner A; Haddad F; Fajardo-Sanchez J; Nguyen E; Thong KX; Ah-Moye S; Perl N; Abu-Bakra M; Kulkarni A; Trikha S; Lascaratos G; Parnell M; Kailani O; King AJ; Agrawal P; Stead R; Giannouladis K; Rodrigues I; Goyal S; Hysi PG; Lim S; Yu-Wai-Man C Br J Ophthalmol; 2023 Aug; 107(8):1104-1111. PubMed ID: 35365491 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma. Strzalkowska A; Strzalkowski P; Hoffmann EM; Pfeiffer N; Schuster AK J Glaucoma; 2023 Aug; 32(8):681-685. PubMed ID: 37327469 [TBL] [Abstract][Full Text] [Related]
18. Long-term results of the safety and effectiveness of a novel microshunt in Japanese patients with primary open-angle glaucoma. Ahmed T; Honjo M; Sakata R; Fujishiro T; Shirato S; Aihara M Jpn J Ophthalmol; 2022 Jan; 66(1):33-40. PubMed ID: 34988757 [TBL] [Abstract][Full Text] [Related]